FDA 510(k) · Microlife Intellectual Property

K141083: MICROLIFE WRIST WATCH BLOOD PRESSURE MONITOR (Microlife Intellectual Property GmbH)

Microlife Intellectual Property GmbH received FDA 510(k) K141083 for MICROLIFE WRIST WATCH BLOOD PRESSURE MONITOR, with a decision date of Aug 22, 2014 (substantially equivalent).

Prescription or OTC: Unknown (no FDA document we parsed states it).

FDA record for K141083FDA summary or statement (PDF)

FDA facts

Official fields for K141083
FDA numberK141083
Pathway510(k)
ApplicantMicrolife Intellectual Property GmbH
Device nameMICROLIFE WRIST WATCH BLOOD PRESSURE MONITOR
Product codeDXN: System, Measurement, Blood-Pressure, Non-Invasive
Regulation (21 CFR)870.1130
Device classClass 2
Date receivedApr 28, 2014
Decision dateAug 22, 2014
DecisionSubstantially Equivalent (SESE)
510(k) typeSpecial

Source: openFDA device 510(k) data, data through Oct 26, 2026.

Indications for use parsed from FDA documents

We could not extract the indications for this record. Check the FDA record for its summary or statement.

Predicates parsed from FDA documents

FDA numbers found next to the word "predicate" in the summary. The list can include reference devices; check the PDF for which device is the primary predicate.

  • K092456 MICROLIFE WRIST WATCH BLOOD PRESSURE MO… (Microlife Intellectual Property)
  • K120430 MICROLIFE WRIST WATCH BLOOD PREEURE MON… (Microlife Intellectual Property)

ChatPPG interpretation

A 510(k) decision of "substantially equivalent" means FDA found the device as safe and effective as a legally marketed predicate. FDA's word for this is cleared, not approved. The clearance covers the device and indications in this submission; it does not extend to other features or versions of the same product that were not part of it. See FDA cleared vs approved.

Product code DXN is "System, Measurement, Blood-Pressure, Non-Invasive", class 2, 21 CFR 870.1130.

Our labels for filtering: claim Blood pressure, sensor Cuff. These are heuristics, not FDA fields.